Zegalogue
Active Ingredient(s): Dasiglucagon HydrochlorideFDA Approved: * March 22, 2021
Pharm Company: * ZEALAND PHARMA
Category: Diabetes
Dasiglucagon, sold under the brand name Zegalogue, is a medication used to treat severe hypoglycemia in people with diabetes.[1][2] The most common side effects include nausea, vomiting, headache, diarrhea, and injection site pain.[1] Dasiglucagon was approved for medical use in the United States in March 2021.[1][3][4][5] It was designated an orphan drug in August 2017.[6&a... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Zegalogue .6 mg/.6ml Subcutaneous Injection, Solution
NDC: 80644-0012
Labeler:
Zealand Pharma Us, Inc
Zegalogue .6 mg/.6ml Subcutaneous Injection, Solution
NDC: 80644-0013
Labeler:
Zealand Pharma Us, Inc